Literature DB >> 29675904

Risk factors for fetal death after radiofrequency ablation for complicated monochorionic twin pregnancies.

Luming Sun1, Gang Zou1, Yingjun Yang1, Fenhe Zhou1, Duan Tao1.   

Abstract

OBJECTIVE: Radiofrequency ablation (RFA) is a management alternative for complicated monochorionic twin pregnancies. The purpose of this study is to evaluate risk factors for fetal death after RFA.
METHODS: An observational study was performed to document the perinatal outcomes of all cases undergoing fetal reduction using RFA from 2010 to 2016 at the Shanghai First Maternity and Infant Hospital. A multiple regression model was built to identify predictors of the death of the remaining fetus after RFA.
RESULTS: A total of 183 patients treated with RFA for fetal reduction were analyzed, including 53 selective intrauterine growth restriction, 35 twin-twin transfusion syndrome, 36 dichorionic triamniotic triplets, 24 monochorionic twins discordant for fetal anomaly, and 35 twin reversed arterial perfusion. The prevalence of fetal death after RFA was 23% (43:183). The occurrence of fetal death after RFA was independently associated with more than 2 cycles of RFA coagulation (OR 3.46; 95% CI, 1.34-8.94; P = .01).
CONCLUSION: More than 2 cycles of RFA coagulation is the only independent risk factors of fetal death after RFA.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29675904     DOI: 10.1002/pd.5269

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Correlation analysis of adverse outcomes for the selective reduction of twin pregnancies.

Authors:  Li Gao; Qian-Qian Xu; Shan Wang; Yuan-Qing Xia; Xin-Rong Zhao; Yi Wu; Ren-Yi Hua; Jin-Ling Sun; Yan-Lin Wang
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-18       Impact factor: 3.105

2.  A cohort study of the perinatal outcome of radiofrequency ablation in complicated monochorionic multiple pregnancies based on a different needle insert angle.

Authors:  Qian Liu; Xiaomei Shi; Liyuan Fang; Tengzi Rao; Lishuang Shi; Jing Wu
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

3.  Outcomes of Monochorionic, Diamniotic Twin Pregnancies with Prenatally Diagnosed Intertwin Weight Discordance.

Authors:  Nasim C Sobhani; Teresa N Sparks; Kristen A Gosnell; Larry Rand; Juan M Gonzalez; Vickie A Feldstein
Journal:  Am J Perinatol       Date:  2020-12-15       Impact factor: 3.079

4.  Influence of indications on perinatal outcomes after radio frequency ablation in complicated monochorionic pregnancies: a retrospective cohort study.

Authors:  Hongmei Wang; Qian Zhou; Xietong Wang; Jia Song; Pengzheng Chen; Yanyun Wang; Lei Li; Hongyan Li
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-09       Impact factor: 3.007

5.  Radiofrequency ablation for selective fetal reduction in complicated Monochorionic twins; comparing the outcomes according to the indications.

Authors:  Fatemeh Rahimi-Sharbaf; Marjan Ghaemi; Ahmed A Nassr; Alireza A Shamshirsaz; Mahboobeh Shirazi
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-06       Impact factor: 3.007

6.  Selective termination of the fetus in multiple pregnancies using ultrasound-guided radiofrequency ablation.

Authors:  Nan Li; Jimei Sun; Jiayan Wang; Wei Jian; Jing Lu; Yonghui Miao; Yufan Li; Fei Chen; Dunjin Chen; Xiaoqing Ye; Min Chen
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-10       Impact factor: 3.007

7.  Comparison of Prenatal and Neonatal Outcomes of Selective Fetal Growth Restriction in Monochorionic Twin Pregnancies with or Without Twin-to-Twin Transfusion Syndrome After Radiofrequency Ablation.

Authors:  Fatemeh Rahimi-Sharbaf; Mahboobeh Shirazi; Fatemeh Golshahi; Zohreh Salari; Mansoureh Haghiri; Marjan Ghaemi; Hanieh Feizmahdavi
Journal:  Iran J Med Sci       Date:  2022-09

8.  Microwave ablation versus radiofrequency ablation for the treatment of severe complicated monochorionic pregnancies in China:protocol for a pilot randomised controlled trial.

Authors:  Jialei Xie; Ziyi Cheng; Tianchen Wu; Yuan Wei; Xiaoli Wang
Journal:  BMJ Open       Date:  2020-08-13       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.